Seenu Hariprasad to Intravitreal Injections
This is a "connection" page, showing publications Seenu Hariprasad has written about Intravitreal Injections.
Connection Strength
1.327
-
Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency. Eur J Ophthalmol. 2021 Mar; 31(2):612-619.
Score: 0.169
-
Intravitreal Injections: Minimizing the Risk and Maximizing Comfort. Ophthalmic Surg Lasers Imaging Retina. 2019 12 01; 51(1):5-8.
Score: 0.168
-
Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure. Indian J Ophthalmol. 2016 Sep; 64(9):643-647.
Score: 0.134
-
DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 01; 47(4):308-12.
Score: 0.130
-
Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T. Ophthalmic Surg Lasers Imaging Retina. 2015 Mar; 46(3):302-5.
Score: 0.121
-
Controversies in the management of Irvine-Gass syndrome. Ophthalmic Surg Lasers Imaging Retina. 2013 Nov 01; 44(6):522-7.
Score: 0.110
-
Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Ocul Immunol Inflamm. 2011 Feb; 19(1):32-8.
Score: 0.089
-
Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration From Major Studies and Real-World Data. Asia Pac J Ophthalmol (Phila). 2023 Mar-Apr 01; 12(2):168-183.
Score: 0.053
-
The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus. Ophthalmic Surg Lasers Imaging Retina. 2023 03; 54(3):166-173.
Score: 0.053
-
Dexamethasone and Anti-VEGF Combination Therapy for the Treatment of Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2019 01 01; 50(1):4-7.
Score: 0.039
-
Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System. Ophthalmic Surg Lasers Imaging Retina. 2018 12 01; 49(12):913-917.
Score: 0.039
-
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome. Am J Ophthalmol. 2017 Dec; 184:121-128.
Score: 0.036
-
Treatment Burden in Neovascular AMD:Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency. Ophthalmic Surg Lasers Imaging Retina. 2017 10 01; 48(10):780-784.
Score: 0.036
-
An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications. Ophthalmic Surg Lasers Imaging Retina. 2017 02 01; 48(2):100-104.
Score: 0.034
-
Treatments for Diabetic Macular Edema: Past, Present, and Future. Ophthalmic Surg Lasers Imaging Retina. 2016 09 01; 47(9):794-800.
Score: 0.033
-
Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 Trials. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):238-44.
Score: 0.032
-
Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration. J Ocul Pharmacol Ther. 2012 Dec; 28(6):581-8.
Score: 0.025
-
Use of intravitreous bevacizumab to treat macular edema in West Nile virus chorioretinitis. Arch Ophthalmol. 2012 Mar; 130(3):396-8.
Score: 0.025